Abstract: (3761 Views)
Background
With modern medical management, thalassemia
major is now extending into adulthood and it is
expected to have a negative impact on the quality of
life (QOL) of the patients. The aim of this study was
to evaluate quality of life in patients with thalassemia
major.
Materials and Methods
This is an analytic case control study. Two hundred
and fifty patients and 51 participants as controls were
assessed using WHOQOL- BREF (Farsi version)
questionnaire. All questions were answered based on
the self-evaluated status in the past 2 weeks before
enrollment and were rated on a five-point Likert
scale. Therefore, the raw item score ranged from 1 to
5 and scaled in a positive direction and 6 dimensions
including overall QOL, overall health, physical,
psychological, social, and environmental relationship
were assessed.
Results
Results showed that the QOL in all 6 dimensions was
lower in patients compared to the controls (P<
0.05).Also age, higher education level, lower ferritin
level and using oral iron chelator were associated
with better QOL scores. On the other hand, cardiac
disease, hepatitis C and history of psychiatric
disorders were associated with impaired QOL scores.
Conclusion
These findings were important for future refinement
of national thalassemia program. So, we
recommended regular screening for psychiatric
disorders and facilitated access to oral iron chelators.
Regular monitoring and treatment of complications
especially cardiac disease and hepatitis along with
strict quality control of blood products were also
mandatory. Also, higher education of the patients
may improve quality of life.
Type of Study:
Research |
Subject:
Heart Received: 2014/06/11 | Accepted: 2014/06/11 | Published: 2014/06/11